 Neuroleptic malignant syndrome Parkinson disease withdrawal alteration dopaminergic therapy Neuroleptic malignant syndrome altered consciousness fever extrapyramidal signs autonomic instability creatine kinase level leukocytosis patients neuroleptic drugs syndrome patients Parkinson disease withdrawal reduction levodopa therapy dopaminergic drug therapy cases neuroleptic malignant syndrome withdrawal levodopa therapy cases variety circumstances alteration therapy dopaminergic drugs syndrome relative unfamiliarity neuroleptic malignant syndrome-levodopa relationship physicians large numbers patients Parkinson disease understanding role brain dopamine pathogenesis neuroleptic malignant syndrome appreciation great variety drugs manipulation fatal syndrome proper timely recognition pharmacologic manipulation neuroleptic drugs